Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Boswellia vs MSM: Boswellia has the stronger overall evidence (7.5 vs 6/10); they're alternatives for joint health & mobility — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Boswellia wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
2 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Boswellia and MSM have evidence — compare verdict strength side-by-side.
300-500mg standardized extract (30-40% AKBA), 2-3x daily (a typical label dose, not the dose used in the cited trials, the one that states its dose gave 100 mg a day of Aflapin, standardized to 20% AKBA)
With meals containing fat
Standardized extract (30-40% AKBA or 65% boswellic acids)
2-3g
With meals, Split into 2-3 doses
Powder or capsules
4-8 weeks
4-8 weeks
2-4 weeks
4-12 weeks
2-4 weeks
8-12 weeks
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Phytotherapy research : PTR (2017) · Meta analysis · n=1741
Z. officinale showed improvement of pain over placebo.
Oral herbal therapies for treating osteoarthritis
The Cochrane database of systematic reviews (2014) · Meta analysis · n=5980
Seventeen studies of confirmatory design (sample and effect sizes pre-specified) were mostly at moderate risk of bias.
Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis
Journal of integrative medicine (2025) · Meta analysis · n=2455
In the WOMAC pain score, the SUCRA of passion fruit peel extract was 91% (mean difference [MD]: -9.2; 95% confidence interval [CI]: [-16.0, -2.3]), followed by methylsulfonylmethane (89%), undenatured type II collagen (87%), collagen (84%), and Lanconone (82%).
Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients (2023) · Rct · n=88
The total scores at 12 weeks in the MSM and placebo groups as the primary outcome were significantly different (p = 0.046).
The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial
Nutrients (2021) · Rct · n=22
The primary finding of this work shows that high-density lipoprotein cholesterol was elevated at 8 and 16 weeks of daily MSM consumption compared to baseline, (p = 0.008, p = 0.013).
The Cochrane review of oral herbal therapies (PMID 24848732) found high-quality evidence from two trials (85 people) that 100 mg a day of an enriched Boswellia serrata extract for 90 days cut pain by 17 points on a 0 to 100 scale against placebo, with fewer adverse events than placebo in one trial. Effectiveness is that pain reduction. A 250 mg dose of enriched extract showed possible benefit in low-quality evidence from a single small study, so it is plotted flat, not higher. Trials of 100 mg Aflapin a day for 30 and 180 days also reduced knee pain against placebo (PMID 35512759, 39700461). A 999 mg dose of a non-enriched extract is a different product and is not plotted. The Cochrane authors state that the optimal daily dose is still to be determined.
The two points come from two separate placebo-controlled trials, not from one trial comparing doses. At 2,000 mg a day (ten 200 mg tablets) for 12 weeks, 88 Japanese adults with mild knee pain improved their total knee score more than placebo (PMID 37447322, p = 0.046). At 6,000 mg a day (3 g twice daily) for 12 weeks, 50 adults with knee osteoarthritis had less WOMAC pain and better physical function than placebo, with no change in stiffness or total symptoms and no major adverse events (PMID 16309928). The populations and scales differ, so the curve is drawn flat: the trials cannot show whether 6 g works better than 2 g. A 16-week trial at 6 g a day found no difference from placebo in blood counts, liver and kidney markers, weight or blood pressure (PMID 31331587). No optimal dose has been established.
AI-estimated from published studies. Interpret as directional guidance.
Boswellia has a higher evidence score (7.5/10 vs 6/10) and wins in 2 of 3 categories.
For joint health & mobility, Boswellia has a higher relevance score (92 vs 62).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.